Changes of general cerebral symptoms in patients with traumatic brain injury and their dependence on the -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene
DOI:
https://doi.org/10.14739/2310-1237.2016.1.71577Keywords:
Traumatic Brain Injury, -675 4G/5G Genetic Polymorphism, Plasminogen Activator Inhibitor-1, Neurologic ManifestationsAbstract
Traumatic brain injury (TBI) is the top place cause of fatality and disability in people of working age. World Health Organization reports more than 10 million cases of traumatic brain injury annually worldwide, of which 1.5 million are fatal.
Control for stabilization of clinical course and resolution of patient neurologic state in acute period of TBI requires especially detailed study with involvement of individual schemes of patients` management.
Diagnostic and prognostic significance of cerebral and meningeal symptoms, which are often inseparable, makes it necessary to monitor constantly this group of disorders and helps to suspect the development of brain secondary lesions and to determine further diagnostic and therapeutic tactics.
The goal of our study is to evaluate the progression of changes in cerebral symptoms in patients with traumatic brain injury depending on the -675 4G/5G polymorphism in the plasminogen activator inhibitor gene.
This article presents an evaluation analysis of the changes that concern cerebral and meningeal signs and symptoms in 200 patients with isolated TBI, and determines the interrelation of the changes with the -675 4G/5G polymorphism in the PAI-1 gene. All patients were treated according to the current recommendations. Examination of the nervous system and evaluation of the cerebral symptoms were performed on the 1st, 7th and 14th day after the hospitalization.
Patients with TBI were divided into 2 groups in accordance with the Glasgow Coma Scale state estimation. Group I (81 patients) included persons with mild traumatic brain injury: concussion and mild brain contusion; group II – 119 patients with severe TBI: severe brain contusion.
In the process of the study, we have found an association between regressive course of cerebral and meningeal symptoms in patients with 4G/4G and 4G/5G genotypes for the studied polymorphism. It was suggested that regressive course of cerebral symptoms in TBI patients is induced by 4G allele and respectively 4G/4G and 4G/5G genotypes for the -675 4G/5G polymorphism in the PAI-1 gene.
References
Huk, A. P. (2013) Epidemiolohiia cherepno-mozkovoi travmy v Ukraini [Epidemiology of traumatic brain injury in Ukraine]. Proceedings of 5th scientific conference, (P. 38). Uzhgorod. [in Ukrainian].
Lekhan, V. M., & Huk, A. P. (2010) Osoblyvosti epidemiolohii cherepno-mozkovoi travmy v Ukraini [Epidemiological peculiarities of traumatic brain injury in Ukraine]. Ukraina. Zdorov’ia natsii, 2, 7–14. [in Ukrainian].
Pedachenko, E. H., Shlapak, I. P., Guk, A. P., Pilipenko, M. N. (2009) Cherepno-mozghovaya travma: sovremennye princypy neotlozhnoj pomoshchi [Traumatic brain injury : the modern principles of first aid]. Кyiv: Vipol. [in Ukrainian].
Genét, G. F., Johansson, P. I., & Meyer, M. A. (2013) Trauma-induced coagulopathy: standard coagulation tests, biomarkers of coagulopathy, and endothelial damage in patients with traumatic brain injury. J. Neurotrauma, 30(4), 301–306. doi: 10.1089/neu.2012.2612.
Huq, M. A., Takeyama, N., & Harada, M. (2012) 4G/5G Polymorphism of the plasminogen activator inhibitor-1 gene is associated with multiple organ dysfunction in critically ill patients. Acta Haematol., 127(2), 72–80. doi: 10.1159/000333130.
Ozolina, A., Strike, E., & Jaunalksne, I. (2012) Influence of PAI-1 Gene Promoter-675 (4G/5G) Polymorphism on Fibrinolytic Activity After Cardiac Surgery Employing Cardiopulmonary Bypass. Medicina (Kaunas), 48(10), 515–520.
Skoromec, A. A., Skoromec, A. P., & Skoromec, T. A. (2012) Nervnye bolezni [Nerve disease]. Moscov: MEDpress-inform. [in Russian].
Balta, G., Altay, C., & Gurgey, A. (2002) PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs. Am. J. Hematol., 71(2), 89–93.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).